Muhammad Ghiyasuddin

Muhammad Ghiyas has extensive experience in the pharmaceutical and healthcare sectors, currently serving as Chief Executive Officer, Managing Director, and Chief Operating Officer at IBL HealthCare Ltd, a subsidiary of Searle, since January 2019. Prior to this role, Muhammad spent over 13 years at Getz Pharma (Private) Limited, where positions included Director of Business Unit and Business Unit Manager, focusing on marketing and sales in various therapeutic segments. Earlier career roles include Product Manager at Organon and Pharmatec Pakistan (Pvt) Ltd. Educational qualifications include a Management Development Program from Lahore University of Management Sciences, an M.Phil. in Organizational Sciences and an MBA from Iqra University, along with a B.Com from Karachi University and a BBA in Marketing from Washington International University.